Kuan-Hung Chen is a Principal Engineer at TSMC, specializing in Chemical Mechanical Polishing. They completed a Ph.D. in Chemical Engineering, during which they conducted extensive oral drug delivery research for diabetes and pancreatic cancer, authored nine research papers in SCI journals, and secured three patents. Previously, Kuan-Hung gained valuable experience as a Product Development Scientist in a global biotech company and a Scientist I at BioLegend, where they launched over 50 flow cytometry antibody products. They are currently involved in developing CAR-T cell therapies at BeiGene, showcasing a strong commitment to advancing global health through cutting-edge research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices